ClinicalTrials.gg
Sign In

Leukemia, Large Granular Lymphocytic clinical trials

The registry lists 144 studies for Leukemia, Large Granular Lymphocytic across more than 10 countries. 19 are recruiting or about to start. 17 of them are mainly about Leukemia, Large Granular Lymphocytic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Leukemia, Large Granular Lymphocytic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
83
Terminated
23
Recruiting
17
Withdrawn
8
Status unknown
6
Active, not recruiting
5

Phase

Phase 1
58
Phase 2
51
Phase 3
15
Early Phase 1
4

Where

United States
113
Germany
12
Italy
11
China
10
France
7
Switzerland
5

Who runs them

National Cancer Institute (NCI) (16) · Fred Hutchinson Cancer Center (11) · Institute of Hematology & Blood Diseases Hospital, China (7) · M.D. Anderson Cancer Center (6) · Case Comprehensive Cancer Center (6) · Northwestern University (5) · European Organisation for Research and Treatment of Cancer - EORTC (4) · Memorial Sloan Kettering Cancer Center (4)

What is being tested here

Drugs under test in Leukemia, Large Granular Lymphocytic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Methotrexate315
Prednisone212
Thalidomide212
Cyclophosphamide117
Etoposide115
Ruxolitinib102
Doxorubicin102
Ifosfamide102
Brentuximab Vedotin102
Golidocitinib101

Drug classes tested here Antimetabolites 3 open · Tyrosine kinase inhibitors (TKIs) 3 open · JAK inhibitors 3 open · Corticosteroids 2 open · Alkylating agents 1 open

Coming up

1phase 3 study under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 17 Leukemia, Large Granular Lymphocytic studies recruiting now, 13 (76%) set no upper age limit and 3 (18%) stop at 75 or younger. 4 (24%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 17
AgeWomenMen
104 (24%)4 (24%)
1816 (94%)16 (94%)
3016 (94%)16 (94%)
4015 (88%)15 (88%)
5015 (88%)15 (88%)
6516 (94%)16 (94%)
7514 (82%)14 (82%)
8514 (82%)14 (82%)

Across all 144 studies, recruiting or not: 22% stop at 75 or younger and 13% at 65; 33% take children; 0% are for women only and 0% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 144. Browse all 144 → or search them.